This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08566/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08566/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08566/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08566/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08566
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB08566 n13:DB08566
dcterms:title
D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID
adms:identifier
n7:SRD n8:46937161 n9:DB08566 n10:99445037
n3:IUPAC-Name
n4:271B6488-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B648E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B648D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B648A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B648B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B648C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6486-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6487-363D-11E5-9242-09173F13E4C5 n4:271B6484-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6485-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6494-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6495-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B648F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6490-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6492-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6491-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6493-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B649A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B649C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B649D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6499-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6498-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B649B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6489-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6496-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6497-363D-11E5-9242-09173F13E4C5